Secondary Logo

November 2018 - Volume 39 - Issue 11
pp: 961-1060

Evaluation of the most commonly used (semi-)quantitative parameters of 18F-FDG PET/CT to detect malignant transformation of neurofibromas in neurofibromatosis type 1

Brinkman, Marloes; Jentjens, Sander; Boone, Kitty; More

Nuclear Medicine Communications. 39(11):961-968, November 2018.


Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer

Abuqbeitah, Mohammad; Demir, Mustafa; Kabasakal, Levent; More

Nuclear Medicine Communications. 39(11):969-975, November 2018.

Docking, synthesis, in-vitro evaluation, and optimization of reaction conditions for direct radiolabeling of CGPRPPC with technetium-99m through the GAGG sequence

Mosayebnia, Mona; Hajiramezanali, Maliheh; Shahhosseini, Soraya; More

Nuclear Medicine Communications. 39(11):976-982, November 2018.

Usefulness of the combination of iodine-123-metaiodobenzylguanidine scintigraphy and iodine-123-ioflupane scintigraphy in new-onset Parkinson’s disease

Okada, Yukinori; Shiraishi, Makoto; Nakamura, Hisao; More

Nuclear Medicine Communications. 39(11):983-988, November 2018.

The efficacy of fluorine-18-choline PET/CT in comparison with 99mTc-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism

Araz, Mine; Soydal, Çigdem; Özkan, Elgin; More

Nuclear Medicine Communications. 39(11):989-994, November 2018.

18F-FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma

Lawal, Ismaheel O.; Ankrah, Alfred O.; Popoola, Gbenga O.; More

Nuclear Medicine Communications. 39(11):1005-1012, November 2018.